Published in J Immunol on October 01, 1979
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci. J Immunol (1976) 4.55
Macrophage Ia antigens. I. macrophage populations differ in their expression of Ia antigens. J Immunol (1978) 4.04
Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci U S A (1988) 3.64
Interaction of gonococci with phagocytic leukocytes from men and mice. Infect Immun (1973) 2.66
Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res (1991) 2.46
Isolation of H-2 alloantigens solubilized by the detergent NP-40. J Immunol (1971) 2.26
Effective dose from cone beam CT examinations in dentistry. Br J Radiol (2008) 2.25
Phenformin and lactic acidosis. Br Med J (1976) 2.20
Nature of the antigenic complex recognized by T lymphocytes: specific sensitization by antigens associated with allogeneic macrophages. Proc Natl Acad Sci U S A (1977) 2.10
Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update (2003) 2.02
Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest (2001) 1.99
Independent populations of primed F1 guinea pig T lymphocytes respond to antigen-pulsed parental peritoneal exudate cells. J Exp Med (1977) 1.88
Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro. J Immunol (1975) 1.85
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79
The management of soft tissue facial wounds. Br J Oral Maxillofac Surg (1995) 1.77
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology (Oxford) (2004) 1.76
Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta (1970) 1.73
Genetic restriction in T-lymphocyte activation by antigen-pulse peritoneal exudate cells. Cold Spring Harb Symp Quant Biol (1977) 1.70
The distribution of alloantigenic specificities of native H-2 products. J Immunol (1972) 1.69
H-2 histocompatibility alloantigens. Some biochemical properties of the molecules solubilized by NP-40 detergent. Biochemistry (1973) 1.68
Nature of the antigenic complex recognized by T lymphocytes. I. Analysis with an in vitro primary response to soluble protein antigens. J Exp Med (1976) 1.68
Studies of Ia antigens on murine peritoneal macrophages. Scand J Immunol (1976) 1.66
Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis. Infect Immun (1972) 1.60
Neonatal cholestasis and hypopituitarism. Arch Dis Child (1984) 1.60
Biguanides and lactic acidosis. Br Med J (1977) 1.59
Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol (1992) 1.58
Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr (1986) 1.57
Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes (1991) 1.57
Regeneration of transplantation antigens on mouse cells. Transplant Proc (1971) 1.56
Pregabalin in patients with postoperative dental pain. Eur J Pain (2001) 1.52
A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol (2000) 1.49
A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother (2005) 1.48
Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease. Gastroenterology (1981) 1.48
The efficacy of low dose thalidomide in refractory/relapsed myeloma: a retrospective audit. Leuk Lymphoma (2006) 1.48
Guinea-pig Ia antigens: functional significance and chemical characterization. Transplant Rev (1976) 1.44
Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers. Pediatrics (1982) 1.44
Cell-surface immunoglobulin human thymus cells and its biosynthesis in vitro. Proc Natl Acad Sci U S A (1973) 1.43
Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum (1980) 1.42
Cross-sectional and longitudinal relationships between physical fitness and risk factors for coronary heart disease in men and women: "the Adelaide 1000". J Clin Epidemiol (1989) 1.39
Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Br Med J (1974) 1.38
Screening laboratory tests for Crohn's disease. West J Med (1989) 1.38
New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus. N Z Med J (1999) 1.37
Regulation of food intake and obesity. Science (1967) 1.35
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34
Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen (2002) 1.34
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol (1998) 1.32
Vitamin D and femoral neck fractures in elderly South Australian women. Med J Aust (1984) 1.31
Insertion of Ia and H-2 alloantigens into model membranes. Proc Natl Acad Sci U S A (1979) 1.31
The role of the macrophage as the stimulator cell in contact sensitivity. J Immunol (1977) 1.28
Complications following intravenous administration of solutions containing xylitol. Med J Aust (1972) 1.28
Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med (1995) 1.28
Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest (1995) 1.27
Acylglucoses of the corynebacteria and mycobacteria. Eur J Biochem (1970) 1.26
HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J Exp Med (1992) 1.25
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1). FEBS Lett (2000) 1.21
Fine specificity of genetic regulation of guinea pig T lymphocyte responses to angiotensin II and related peptides. J Exp Med (1981) 1.20
Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line. J Immunol (1987) 1.18
Effects of drugs on clinical laboratory tests. Clin Chem (1972) 1.17
Climate and resource determinants of fundamental and realized metabolic niches of hibernating chipmunks. Ecology (2008) 1.16
Hyperglycaemia in the urbanized Aboriginal. The Davenport survey. Med J Aust (1970) 1.14
Nature of T lymphocyte recognition of macrophage-associated antigens. I. Response of guinea pig T cells to human fibrinopeptide B. J Immunol (1979) 1.14
Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease. J Pediatr Gastroenterol Nutr (1983) 1.13
Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol (2003) 1.13
Discovery of genes for ginsenoside biosynthesis by analysis of ginseng expressed sequence tags. Plant Cell Rep (2003) 1.13
The molecular basis of codominant expression of the histocompatibility-2 genetic region. Proc Natl Acad Sci U S A (1972) 1.13
Habitat filtering across tree life stages in tropical forest communities. Proc Biol Sci (2013) 1.12
A randomised controlled trial of clinical outreach education to rationalise antibiotic prescribing for acute dental pain in the primary care setting. Br Dent J (2006) 1.12
Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins. J Immunol (1985) 1.11
Langerhans cell histiocytosis in sequential discordant lymphoma. J Clin Pathol (2005) 1.11
Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J Immunol (1995) 1.10
Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals. J Clin Invest (1982) 1.10
T lymphocyte stimulation by hapten-conjugated macrophages: a model system for the study of immunocompetent cell interactions. Immunol Rev (1978) 1.09
Identification of the genes encoding enzymes involved in the early biosynthetic pathway of pteridines in Synechocystis sp. PCC 6803. FEMS Microbiol Lett (1999) 1.09
Use of monoclonal antihapten antibodies for immunolocalisation of tissue antigens. J Clin Pathol (1981) 1.09
Identification of a new component in the murine Ia molecular complex. J Exp Med (1983) 1.09
Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan. J Exp Med (1985) 1.09
Blood pressures and electrocardiographic findings in the South Australian Aborigines. Aust N Z J Med (1976) 1.08
Purification of human brain tissue factor. J Biol Chem (1985) 1.08
Identification of crystals deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods. J Clin Pathol (1973) 1.07
Nature of T lymphocyte recognition of macrophage-associated antigens. II. Macrophage determination of guinea pig T cell responses to human fibrinopeptide B. J Immunol (1979) 1.07
The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies. J Immunol (1975) 1.07
Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med (1992) 1.06
Evaluation of an immunological test for occult bleeding from colorectal neoplasia. Aust N Z J Surg (1982) 1.05
Nature of T lymphocyte recognition of macrophage-associated antigens. V. Contribution of individual peptide residues of human fibrinopeptide B to T lymphocyte responses. J Exp Med (1980) 1.05
Nature of the antigenic complex recognized by T lymphocytes. VI. The effect of anti-TNP antibody on T cell responses to TNP-conjugated macrophages. J Immunol (1978) 1.05
Nature of the antigenic complex recognized by T lymphocytes. VII. Evidence for an association between TNP-conjugated macrophage membrane components and Ia antigens. J Immunol (1978) 1.04
Identification of a sulfate-bearing molecule associated with HLA class II antigens. Proc Natl Acad Sci U S A (1984) 1.04
Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype. J Biol Chem (1986) 1.04
Human recombinant soluble CD4 therapy. Lancet (1990) 1.03
YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes. J Exp Med (1994) 1.03
The guinea pig I region. II. Functional analysis. J Exp Med (1977) 1.01